Nationwide genetic analysis of more than 600 families with inherited eye diseases in Argentina.
Patricio G SchlottmannJosé Domingo Luna PintoNatalia LabatMaría Belén YadarolaSilvina BaintteinEvangelina EspositoAgustina IbañezEvangelina Ivón BarbaroAlejandro Álvarez MendiaraCarolina P PicottiAndrea Chirino MisisianLuciana AndreussiJulieta GrasLuciana CapalboMauro VisottoJosé Edgardo DipierriEmilio AlcobaLaura Fernández GabrielliSilvia ÁvilaMaría Emilia AucarDaniel M MartinGerardo Juan OrmaecheaM Eugenia IngaAníbal A FranconeMartin CharlesTamara ZompaPablo Javier PérezVanesa LoterszteinPedro J NuovaIvana B CanoneroOmar A MahrooMichel MichaelidesGavin ArnoMalena Daich VarelaPublished in: NPJ genomic medicine (2023)
This study corresponds to the first large-scale genetic analysis of inherited eye diseases (IED) in Argentina and describes the comprehensive genetic profile of a large cohort of patients. Medical records of 22 ophthalmology and genetics services throughout 13 Argentinian provinces were analyzed retrospectively. Patients with a clinical diagnosis of an ophthalmic genetic disease and a history of genetic testing were included. Medical, ophthalmological and family history was collected. A total of 773 patients from 637 families were included, with 98% having inherited retinal disease. The most common phenotype was retinitis pigmentosa (RP, 62%). Causative variants were detected in 379 (59%) patients. USH2A, RPGR, and ABCA4 were the most common disease-associated genes. USH2A was the most frequent gene associated with RP, RDH12 early-onset severe retinal dystrophy, ABCA4 Stargardt disease, PROM1 cone-rod dystrophy, and BEST1 macular dystrophy. The most frequent variants were RPGR c.1345 C > T, p.(Arg449*) and USH2A c.15089 C > A, p.(Ser5030*). The study revealed 156/448 (35%) previously unreported pathogenic/likely pathogenic variants and 8 possible founder mutations. We present the genetic landscape of IED in Argentina and the largest cohort in South America. This data will serve as a reference for future genetic studies, aid diagnosis, inform counseling, and assist in addressing the largely unmet need for clinical trials to be conducted in the region.
Keyphrases
- early onset
- end stage renal disease
- copy number
- ejection fraction
- genome wide
- clinical trial
- newly diagnosed
- peritoneal dialysis
- healthcare
- chronic kidney disease
- primary care
- hiv infected
- late onset
- big data
- gene expression
- electronic health record
- double blind
- human immunodeficiency virus
- placebo controlled
- dna methylation
- study protocol
- smoking cessation